2025-04-22 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Report

**0. Key Figures & Initial Analysis:**

ISRG (Intuitive Surgical Inc.) is a leading developer and manufacturer of robotic surgical systems.  The provided data shows a significantly higher cumulative return for ISRG compared to the S&P 500 (VOO).


**1. Performance Comparison with S&P 500 (VOO):**

* **ISRG Cumulative Return:** 103.06%
* **VOO Cumulative Return:** 72.42%
* **Return Difference:** 30.64%  This means ISRG outperformed the S&P 500 by 30.64% over the period considered.  The relative divergence of 35.4% indicates that this outperformance is above the average historical difference,  but the range (min -14.2%, max 112.2%) suggests significant variability.

**Alpha and Beta Analysis:**

The provided data shows that ISRG generally exhibits a high beta (above 1), indicating higher volatility than the market.  Alpha values fluctuate, suggesting periods of outperformance and underperformance relative to the market. Notably, the recent years (2021-2025) show a consistently positive alpha, indicating stronger outperformance, but this also comes with increased risk due to high beta.  The market capitalization (Cap(B)) has shown steady growth throughout the period.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 68.0% | 56.5% | 35.0% | -0.0 | 44.9 |
| 2016-2018  | 77.0% | 63.4% | 56.0% | -0.1 | 59.0 |
| 2017-2019  | 81.0% | 63.4% | 47.0% | 0.4 | 72.8 |
| 2018-2020  | 47.0% | 63.4% | 17.0% | 0.4 | 100.7 |
| 2019-2021  | 91.0% | 63.0% | 31.0% | 0.4 | 132.7 |
| 2020-2022  | -3.0% | 69.9% | -12.0% | 0.5 | 98.0 |
| 2021-2023  | -5.0% | 72.9% | -26.0% | 1.1 | 124.6 |
| 2022-2024  | 26.0% | 72.9% | 5.0% | 1.1 | 192.8 |
| 2023-2025  | 24.0% | 72.9% | 13.0% | 0.7 | 172.9 |


**2. Recent Price Movement:**

* **Closing Price:** $468.32
* **5-Day Moving Average:** $482.16
* **20-Day Moving Average:** $491.01
* **60-Day Moving Average:** $534.75

The stock price is currently below all three moving averages, suggesting a possible downward trend.  The recent price change of -$2.99 indicates a short-term decline.


**3. Technical Indicators:**

* **Market Risk Indicator (MRI):** 0.4082 (Medium Risk)
* **RSI:** 43.77 (Approaching oversold territory, but not yet definitively so)
* **PPO:** 0.176 (Positive, indicating bullish momentum, but relatively weak)
* **20-Day Relative Divergence Change:** -3.2% (Short-term downward trend)
* **Expected Return (vs. S&P 500):** 51.1% over the long term (2+ years) â€“ This highlights a significant potential for outperformance given a long-term investment horizon.


**4. Recent Earnings Analysis:**

The earnings data shows a generally increasing trend in both EPS and Revenue, with some minor fluctuations.  However, there's a duplicate entry for Oct 18, 2024, which needs clarification.  Further analysis requires more context and potentially a comparison to previous years' earnings.


| Date       | EPS  | Revenue    |
|------------|------|------------|
| 2024-10-18 | 1.59 | $2.04 B    |
| 2024-07-19 | 1.48 | $2.01 B    |
| 2024-04-19 | 1.54 | $1.89 B    |
| 2023-10-20 | 1.18 | $1.74 B    |
| 2024-10-18 | 1.18 | $1.74 B    | *(Duplicate Entry)*


**5. Financial Information:**

Both Revenue and Profitability show a relatively stable and healthy performance. Profit margins are consistently high, indicating efficient operations. Equity is growing, but the Return on Equity (ROE) fluctuates, suggesting some variability in profitability relative to invested capital.


Revenue and Profitability:

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $2.41B | 68.04% |
| 2024-09-30 | $2.04B | 67.41% |
| 2024-06-30 | $2.01B | 68.30% |
| 2024-03-31 | $1.89B | 65.87% |
| 2023-12-31 | $1.93B | 66.24% |

Capital and Profitability:

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2024-12-31 | $16.43B | 4.17% |
| 2024-09-30 | $15.58B | 3.63% |
| 2024-06-30 | $14.71B | 3.58% |
| 2024-03-31 | $13.96B | 3.90% |
| 2023-12-31 | $13.31B | 4.56% |


**6. Overall Analysis:**

ISRG has demonstrated strong historical performance, significantly outperforming the S&P 500.  However, this comes with higher volatility (high beta).  Current indicators suggest a potential short-term downward trend, but the long-term outlook remains positive, with a high expected return compared to the market.  Further investigation into the duplicate earnings entry and a deeper analysis of historical performance beyond the provided data are needed for a comprehensive assessment.  The high profit margins and growing revenue suggest a healthy and robust business model.  Long-term investors with a higher risk tolerance could consider ISRG, but short-term investors should exercise caution due to the current downward trend.
